Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Cyteir Therapeutics

Request full access

Developing the next generation of synthetic lethal therapies to treat cancer

Lexington, United StatesFounded 2012Biotech & Life Sciences

About Cyteir Therapeutics

Cyteir Therapeutics is a pioneering biotechnology company focused on developing novel therapeutics for cancer treatment through the biology of DNA repair and synthetic lethality. The company operates in the oncology market, primarily serving patients with various types of cancer. Cyteir's business model revolves around the discovery and development of drugs that induce selective self-destruction of cancer cells by targeting disease-induced RAD51 activity, leading to DNA damage overload. Revenue is generated through the development and commercialization of these specialized cancer therapies, as well as potential partnerships and licensing agreements with larger pharmaceutical companies.

Source: Dealroom company data

Cyteir Therapeutics in the Lexington ecosystem

Live from Dealroom

The Cyteir Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

17 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed2 investors entered at this stage

  • US Department of Health and Human Services
  • National Cancer Institute (NCI)

Series A7 investors entered at this stage

  • Bristol-Myers Squibb
  • Venrock
  • Novo Seeds
  • Novo Holdings
  • Droia Oncology Ventures
  • Lightstone Ventures
  • Celgene

Series B and later8 investors entered at this stage

Team profiled 8 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Cyteir Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Cyteir Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.